Abiopharma

Fractyl Health to Report Third Quarter 2025 Financial Results and Provide Business Updates on November 12, 2025

Clearmind Expands Global IP Protection for MEAI in Depression Treatment with New South Korea Patent Filing

Perrigo Reports Third Quarter 2025 Financial Results From Continuing Operations

BIO-TECHNE DECLARES DIVIDEND

Compass Pathways to Participate in Stifel 2025 Healthcare Conference

Perrigo to Conduct Strategic Review of its Infant Formula Business

Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results

Ocugen Provides Business Update with Third Quarter 2025 Financial Results

Cencora Reports Fiscal 2025 Fourth Quarter and Fiscal Year End Results

Fortrea Reports Third Quarter 2025 Results